Health Catalyst (HCAT) Common Equity (2018 - 2026)

Health Catalyst's Common Equity history runs 9 years deep, the most recent figure standing at $138.1 million for Q1 2026.

• Quarterly Common Equity fell 63.34% year-over-year to $138.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $138.1 million (down 63.34% YoY) and the FY2025 annual result came in at $245.8 million, down 32.7% from the prior year.
• Common Equity was $138.1 million for Q1 2026 at Health Catalyst, down from $245.8 million in the prior quarter.
• Across five years, Common Equity topped out at $480.9 million in Q1 2022 and bottomed at $138.1 million in Q1 2026.
• A 5-year average of $366.7 million and a median of $366.9 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity jumped 78.89% — and 2026, when it tumbled 63.34%.
• Health Catalyst's Common Equity stood at $425.0 million in 2022, then declined by 13.67% to $366.9 million in 2023, then dropped by 0.47% to $365.2 million in 2024, then slumped by 32.7% to $245.8 million in 2025, then plunged by 43.79% to $138.1 million in 2026.
• Business Quant data shows HCAT's Common Equity at $138.1 million in Q1 2026, $245.8 million in Q4 2025, and $331.9 million in Q3 2025.